Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1983 1
1985 1
1990 1
1991 2
1992 3
1993 1
1994 5
1995 1
1996 3
1997 2
1998 6
1999 4
2000 3
2001 5
2002 2
2003 6
2004 9
2005 12
2006 10
2007 12
2008 7
2009 16
2010 12
2011 20
2012 15
2013 16
2014 13
2015 14
2016 23
2017 18
2018 13
2019 13
2020 18
2021 19
2022 16
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Yu EY, Piulats JM, Gravis G, Fong PCC, Todenhöfer T, Laguerre B, Arranz JA, Oudard S, Massard C, Heinzelbecker J, Nordquist LT, Carles J, Kolinsky MP, Augustin M, Gurney H, Tafreshi A, Li XT, Qiu P, Poehlein CH, Schloss C, de Bono JS. Yu EY, et al. Among authors: arranz ja. Eur Urol. 2023 Jan;83(1):15-26. doi: 10.1016/j.eururo.2022.08.005. Epub 2022 Aug 30. Eur Urol. 2023. PMID: 36055895 Free article. Clinical Trial.
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, Plimack ER, Vaena D, Grimm MO, Bracarda S, Arranz JÁ, Pal S, Ohyama C, Saci A, Qu X, Lambert A, Krishnan S, Azrilevich A, Galsky MD. Sharma P, et al. Among authors: arranz ja. Lancet Oncol. 2017 Mar;18(3):312-322. doi: 10.1016/S1470-2045(17)30065-7. Epub 2017 Jan 26. Lancet Oncol. 2017. PMID: 28131785 Clinical Trial.
[De-escalation: Testicular cancer.].
Mayor J, Álvarez-Maestro M, Arranz JÁ, Laguna MP. Mayor J, et al. Among authors: arranz ja. Arch Esp Urol. 2020 Jun;73(5):390-394. Arch Esp Urol. 2020. PMID: 32538809 Free article. Spanish.
Sorafenib in renal cell carcinoma.
Arranz JÁ, Climent MÁ, González-Larriba JL, León L, Maroto JP. Arranz JÁ, et al. Crit Rev Oncol Hematol. 2011 Nov;80(2):314-22. doi: 10.1016/j.critrevonc.2011.01.008. Epub 2011 Mar 21. Crit Rev Oncol Hematol. 2011. PMID: 21419641 Review.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Herzog TJ, Pignata S, Ghamande SA, Rubio MJ, Fujiwara K, Vulsteke C, Armstrong DK, Sehouli J, Coleman RL, Gabra H, Scambia G, Monk BJ, Arranz JA, Ushijima K, Hanna R, Zamagni C, Wenham RM, González-Martín A, Slomovitz B, Jia Y, Ramsay L, Tewari KS, Weil SC, Vergote IB. Herzog TJ, et al. Among authors: arranz ja. Gynecol Oncol. 2023 Mar;170:300-308. doi: 10.1016/j.ygyno.2023.01.003. Epub 2023 Feb 7. Gynecol Oncol. 2023. PMID: 36758420 Clinical Trial.
Successful desensitisation to paclitaxel with omalizumab.
Barreras N, Gómez-López A, Valverde M, Arranz JL, Castillo E, Hernandez M. Barreras N, et al. Among authors: arranz jl. Eur J Hosp Pharm. 2023 Oct 5:ejhpharm-2023-003809. doi: 10.1136/ejhpharm-2023-003809. Online ahead of print. Eur J Hosp Pharm. 2023. PMID: 37798087
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
Rozalem Aranha M, Iulita MF, Montal V, Pegueroles J, Bejanin A, Vaqué-Alcázar L, Grothe MJ, Carmona-Iragui M, Videla L, Benejam B, Arranz J, Padilla C, Valldeneu S, Barroeta I, Altuna M, Fernández S, Ribas L, Valle-Tamayo N, Alcolea D, González-Ortiz S, Bargalló N, Zetterberg H, Blennow K, Blesa R, Wisniewski T, Busciglio J, Cuello AC, Lleó A, Fortea J. Rozalem Aranha M, et al. Among authors: arranz j. Alzheimers Dement. 2023 Nov;19(11):4817-4827. doi: 10.1002/alz.12999. Epub 2023 Apr 6. Alzheimers Dement. 2023. PMID: 37021589
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F. Luque M, et al. Among authors: arranz jl. Cancers (Basel). 2022 Dec 8;14(24):6034. doi: 10.3390/cancers14246034. Cancers (Basel). 2022. PMID: 36551522 Free PMC article. Review.
Latest progress in molecular biology and treatment in genitourinary tumours.
González-Del-Alba A, Arranz JÁ, Bellmunt J, Maroto JP, Fernández-Calvo O, Valderrama BP, González-Billalabeitia E, Méndez-Vidal MJ, Cassinello J, Romero-Laorden N, Climent MÁ, Puente J, Peláez I, Lázaro-Quintela M, Gallardo E, Suárez C. González-Del-Alba A, et al. Among authors: arranz ja. Clin Transl Oncol. 2020 Dec;22(12):2175-2195. doi: 10.1007/s12094-020-02373-z. Epub 2020 May 21. Clin Transl Oncol. 2020. PMID: 32440915 Review.
Evolving synergetic interactions.
Wu B, Arranz J, Du J, Zhou D, Traulsen A. Wu B, et al. Among authors: arranz j. J R Soc Interface. 2016 Jul;13(120):20160282. doi: 10.1098/rsif.2016.0282. J R Soc Interface. 2016. PMID: 27466437 Free PMC article.
298 results